Preoperative statins and limb salvage after lower extremity revascularization in the medicare population

Circulation: Cardiovascular Interventions

Volumn 6, Issue 6, 2013, Pages 694-700

  Vogel, Todd R ^a   Dombrovskiy, Viktor Y ^c   Galiñanes, Edgar Luis ^a   Kruse, Robin L ^b  

^a UNIVERSITY OF MISSOURI   (United States)

^b University of Missouri   (United States)

^c ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Amputations; Survival analysis; Vascular surgical procedures

Indexed keywords

ATORVASTATIN; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; PITAVASTATIN; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

AGED; AMPUTATION; ARTICLE; ATHEROSCLEROSIS; CURRENT PROCEDURAL TERMINOLOGY; ENDOVASCULAR SURGERY; FEMALE; GANGRENE; HUMAN; ICD-9; INTERMITTENT CLAUDICATION; LEG REVASCULARIZATION; LIMB SALVAGE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDICARE; PAIN; PREOPERATIVE CARE; PRIORITY JOURNAL; SURVIVAL; ULCER; VERY ELDERLY;

AMPUTATIONS; SURVIVAL ANALYSIS; VASCULAR SURGICAL PROCEDURES;

AGED; AGED, 80 AND OVER; AMPUTATION; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INCIDENCE; KAPLAN-MEIER ESTIMATE; LIMB SALVAGE; LOWER EXTREMITY; MALE; MEDICARE; PERIPHERAL ARTERIAL DISEASE; PREOPERATIVE CARE; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL RATE; UNITED STATES; VASCULAR SURGICAL PROCEDURES;

EID: 84892417336     PISSN: 19417640     EISSN: 19417632     Source Type: Journal    
DOI: 10.1161/CIRCINTERVENTIONS.113.000274     Document Type: Article

References (22)

1. Le Manach Y, Coriat P, Collard CD, Riedel B. Statin therapy within the perioperative period. Anesthesiology. 2008;108:1141-1146.
2. Ray KK, Cannon CP. Lipid-independent pleiotropic effects of statins in the management of acute coronary syndromes. Curr Treat Options Cardiovasc Med. 2007;9:46-51.
3. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the scandinavian simvastatin survival study (4S). Lancet. 1994;344:1383-1389.
4. Mrc/bhf heart protection study of cholesterol lowering with simvastatin in 20, 536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360:7-22.
5. Stalenhoef AF. The benefit of statins in non-cardiac vascular surgery patients. J Vasc Surg. 2009;49:260-265.
6. Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20, 536 people with peripheral arterial disease and other high-risk conditions. J Vasc Surg. 2007;45:645-654; discussion 653-644.
7. Leurs LJ, Visser P, Laheij RJ, Buth J, Harris PL, Blankensteijn JD. Statin use is associated with reduced all-cause mortality after endovascular abdominal aortic aneurysm repair. Vascular. 2006;14:1-8.
8. Dhaliwal G, Mukherjee D. Peripheral arterial disease: Epidemiology, natural history, diagnosis and treatment. Int J Angiol. 2007;16:36-44.
9. Rice TW, Lumsden AB. Optimal medical management of peripheral arterial disease. Vasc Endovascular Surg. 2006;40:312-327.
10. Pan W, Pintar T, Anton J, Lee VV, Vaughn WK, Collard CD. Statins are associated with a reduced incidence of perioperative mortality after coronary artery bypass graft surgery. Circulation. 2004;110(11 suppl 1):II45-II49.
11. O'Neil-Callahan K, Katsimaglis G, Tepper MR, Ryan J, Mosby C, Ioannidis JP, Danias PG. Statins decrease perioperative cardiac complications in patients undergoing noncardiac vascular surgery: the Statins for Risk Reduction in Surgery (StaRRS) study. J Am Coll Cardiol. 2005;45:336-342.
12. Poldermans D, Bax JJ, Kertai MD, Krenning B, Westerhout CM, Schinkel AF, Thomson IR, Lansberg PJ, Fleisher LA, Klein J, van Urk H, Roelandt JR, Boersma E. Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery. Circulation. 2003;107:1848-1851.
13. Davis M, Atwal AS, Nair DR, Jagroop IA, Seifalian AM, Mikhailidis DP, Hamilton G. The effect of short-term lipid lowering with atorvastatin on carotid artery intima media thickness in patients with peripheral vascular disease: a pilot study. Curr Med Res Opin. 2000;16:198-204.
14. Alnaeb ME, Alobaid N, Seifalian AM, Mikhailidis DP, Hamilton G. Statins and peripheral arterial disease: potential mechanisms and clinical benefits. Ann Vasc Surg. 2006;20:696-705.
15. Aiello FA, Khan AA, Meltzer AJ, Gallagher KA, McKinsey JF, Schneider DB. Statin therapy is associated with superior clinical outcomes after endovascular treatment of critical limb ischemia. J Vasc Surg. 2012;55:371-9; discussion 380.
16. Gasper WJ, Runge SJ, Owens CD. Management of infrapopliteal peripheral arterial occlusive disease. Curr Treat Options Cardiovasc Med. 2012;14:136-148.
17. Le Manach Y, Godet G, Coriat P, Martinon C, Bertrand M, Fléron MH, Riou B. The impact of postoperative discontinuation or continuation of chronic statin therapy on cardiac outcome after major vascular surgery. Anesth Analg. 2007;104:1326-1333, table of contents.
18. Paraskevas KI, Hamilton G, Mikhailidis DP, Liapis CD. Optimal medical management of peripheral arterial disease. Vasc Endovascular Surg. 2007;41:87.
19. Gómez-Hernández A, Sánchez-Galán E, Martín-Ventura JL, Vidal C, Blanco-Colio LM, Ortego M, Vega M, Serrano J, Ortega L, Hernández G, Tunón J, Egido J. Atorvastatin reduces the expression of prostaglandin E2 receptors in human carotid atherosclerotic plaques and monocytic cells: potential implications for plaque stabilization. J Cardiovasc Pharmacol. 2006;47:60-69.
20. Conte MS, Bandyk DF, Clowes AW, Moneta GL, Namini H, Seely L. Risk factors, medical therapies and perioperative events in limb salvage surgery: observations from the PREVENT III multicenter trial. J Vasc Surg. 2005;42:456-464; discussion 464.
21. Khan S, Flather M, Mister R, Delahunty N, Fowkes G, Bradbury A, Stansby G. Characteristics and treatments of patients with peripheral arterial disease referred to UK vascular clinics: results of a prospective registry. Eur J Vasc Endovasc Surg. 2007;33:442-450.
22. Aubert RE, Yao J, Xia F, Garavaglia SB. Is there a relationship between early statin compliance and a reduction in healthcare utilization? Am J Manag Care. 2010;16:459-466.